Haeme oxygenase signalling pathway: implications for cardiovascular disease

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Molecular Biology

Background:

• The haeme oxygenase (HO) pathway is implicated in cardiovascular disease (CVD) pathogenesis.
• HO pathway activity modulates oxidative stress, inflammation, and vasoregulation.
• Understanding HO's role is crucial for cardiovascular health.

Purpose of the Study:

• To review experimental and clinical data on the HO pathway's role in CVD.
• To identify research gaps and suggest future directions.
• To evaluate the HO pathway as a therapeutic target for CVD.

Main Methods:

• Literature review of experimental studies.
• Analysis of emerging clinical data.
• Synthesis of evidence on HO pathway mechanisms in CVD.

Main Results:

• Accumulating evidence suggests the HO pathway influences CVD development.
• HO pathway products may act as endogenous modulators of stress and vascular function.
• Genetic, environmental, and pharmacological factors influence HO activity.

Conclusions:

• The HO pathway is a potential therapeutic target for reducing CVD risk.
• Further investigation is required to establish HO pathway products as prognostic markers.
• Modulating HO activity may offer a novel strategy for CVD management.